Cvs Pharmacy #02125 Durable Medical Equipment & Medical Supplies Location: 137 West Central St, Natick, Massachusetts 01760 Phone: (508) 655-2271 |
Simon Medical Services, Inc. Durable Medical Equipment & Medical Supplies Location: 19 Tech Cir, Natick, Massachusetts 01760 Phone: (508) 655-0978 |
Walgreens #1851 Durable Medical Equipment & Medical Supplies Location: 148 W Central St, Natick, Massachusetts 01760 Phone: (508) 653-3303 |
Stop & Shop Pharmacy #6 Durable Medical Equipment & Medical Supplies Location: 829 Worcester St, Natick, Massachusetts 01760 Phone: (508) 653-3504 |
Natick Family Pharmacy Inc Durable Medical Equipment & Medical Supplies Location: 67 Union St, Natick, Massachusetts 01760 Phone: (508) 720-4971 |
Nordstrom Prosthetic/Orthotic Supplier Location: 290 Speen St, Natick, Massachusetts 01760 Phone: (508) 318-2600 |
Byrne Home Health Center DME Supplier - Oxygen Equipment & Supplies Location: 16 Main St, Natick, Massachusetts 01760 Phone: (508) 655-3656 |
Lenscrafters #00246 Eyewear Supplier (Equipment, not the service) Location: 1364 Worcester St, Natick, Massachusetts 01760 Phone: (508) 653-2102 |
Lenscrafters Optique #00667 Eyewear Supplier (Equipment, not the service) Location: 1245 Worcester St, Natick, Massachusetts 01760 Phone: (508) 653-0223 |
News Archive
New research published by the Neuronal Mechanism for Critical Period Unit at the Okinawa Institute of Science and Technology Graduate University has shown the effectiveness of chemogenetic inhibition used to suppress neuronal activity as well as interesting results on how vocalization is controlled through this techniques application in zebra finches.
UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations of Semitic descent, particularly families from Saudi Arabia.
Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has been notified by AstraZeneca that marketing and pricing approval for VIMOVO™ (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets, has been granted in the United Kingdom (UK).
› Verified 7 days ago